COVID-19, Angiotensin Receptor Blockers, and the Brain

被引：27
作者：
Saavedra, Juan M. [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, 3900 Reservoir Rd NW, Washington, DC 20057 USA
来源：
CELLULAR AND MOLECULAR NEUROBIOLOGY | 2020年 / 40卷 / 05期
关键词：
CONVERTING ENZYME 2; BRONCHIAL EPITHELIAL-CELLS; SARS CORONAVIRUS; INHIBITORS; ACE2; PNEUMONIA; ENTRY; ASSOCIATION; PROTEIN; RISK;
D O I：
10.1007/s10571-020-00861-y
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：667 / 674
页数：8
相关论文
共 79 条
  • [11] Clinical Experience with the Use of Angiotensin Receptor Blockers in Patients with Cardiovascular, Cerebrovascular and Renal Diseases
    Chrysant, Steven G.
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2006, 1 (02): : 139 - 146
  • [12] Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation
    Clancy, Paula
    Koblar, Simon A.
    Golledge, Jonathan
    [J]. ATHEROSCLEROSIS, 2014, 236 (01) : 108 - 115
  • [13] Aging and the Renin-Angiotensin System
    Conti, Sara
    Cassis, Paola
    Benigni, Ariela
    [J]. HYPERTENSION, 2012, 60 (04) : 878 - 883
  • [14] Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
    Diaz, James H.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2020, 27 (03)
  • [15] Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPAR Activation
    Elkahloun, Abdel G.
    Rodriguez, Yara
    Alaiyed, Seham
    Wenzel, Erin
    Saavedra, Juan M.
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (05) : 3193 - 3210
  • [16] European Society of Cardiology, 2020, POSITION STATEMENT E
  • [17] Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
    Fang, Lei
    Karakiulakis, George
    Roth, Michael
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (04) : E21 - E21
  • [18] Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola
    Fedson, David S.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (21)
  • [19] INFLUENZA-VIRUS ANTIGEN IN POSTENCEPHALITIC PARKINSONISM BRAIN
    GAMBOA, ET
    WOLF, A
    HARTER, DH
    DUFFY, PE
    BARDEN, H
    HSU, KC
    YAHR, MD
    [J]. ARCHIVES OF NEUROLOGY, 1974, 31 (04) : 228 - 232
  • [20] Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
    Gurwitz, David
    [J]. DRUG DEVELOPMENT RESEARCH, 2020, 81 (05) : 537 - 540
12345678